Intravitreal injection of bevacizumab (Avastin®) for retinal angiomatous proliferation;Inyección intravítrea de bevacizumab (Avastin®) para proliferación angiomatosa retiniana

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 83, Issue 1, 2008, Pages 53-56

  Amselem, L ^a   Diaz Llopis M ^a   Cervera, E ^a   Garcia Delpech S ^a   Moratal Peiro, B ^a   Palomares, P ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Age related macular degeneration; Bevacizumab; Intravitreal injection; Optical coherence tomography; Retinal angiomatous proliferation

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY;

AGED; ARTICLE; CASE REPORT; HUMAN; INJECTION; MALE; PATHOLOGY; RETINA MACULA DEGENERATION; RETINA NEOVASCULARIZATION; VITREOUS BODY;

AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; RETINAL NEOVASCULARIZATION; VITREOUS BODY;

EID: 41149127275     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416-434.
2. Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C. Photodynamic therapy for retinal angiomatous proliferation and pigment epithelium detachment. Am J Ophthalmol 2004; 138: 1077-1079.
3. Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study. Opthalmology 2005; 112: 1035-1047.
4. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005; 36: 336-339.
5. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005; 36: 331-335.